This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA

Srivatsan Ramesh, Ph.D.
Process Development Scientist at BridgeBio Gene Therapy
Speaker

Profile

Srivatsan Ramesh is a process development scientist at BridgeBio with more than three years of bioprocessing experience, advancing various programs from early research through late-stage development, including leading process validation studies, and pivotal/BLA-enabling studies. He has a proven track record in designing development studies, leading tech transfers to CDMOs, and overseeing GMP manufacturing to support clinical and regulatory milestones. He holds a Ph.D. in Chemical and Biomolecular Engineering from North Carolina State University.

Agenda Sessions

  • Ensuring Viral Safety in AAV9 Gene Therapy Program: Potentially Platformable Approach that Delivers Robust Clearance

    2:30pm